Pitfalls in retrospective analyses of biomarkers: A case study with metastatic melanoma patients
- 28 February 2012
- journal article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 376 (1-2), 108-112
- https://doi.org/10.1016/j.jim.2011.12.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Regional Recurrence in Breast Cancer Patients With Sentinel Node Micrometastases and Isolated Tumor CellsAnnals of Surgery, 2012
- Multiplex serum biomarker assessments: technical and biostatistical issuesJournal of Translational Medicine, 2011
- Effect of Occult Metastases on Survival in Node-Negative Breast CancerNew England Journal of Medicine, 2011
- Nodal-Stage Classification in Invasive Lobular Breast Carcinoma: Influence of Different Interpretations of the pTNM ClassificationJournal of Clinical Oncology, 2010
- More tumor‐affected lymph nodes because of the sentinel lymph node procedure but no stage migration, because the 2002 TNM classifies small tumor deposits as pathologic N0 breast cancerCancer, 2009
- Micrometastases or Isolated Tumor Cells and the Outcome of Breast CancerNew England Journal of Medicine, 2009
- Prerequisites for cytokine measurements in clinical trials with multiplex immunoassaysBMC Immunology, 2009
- Distinction between isolated tumor cells and micrometastases in breast cancerCancer, 2008
- Cutaneous melanomaThe Lancet, 2005
- Improving the reproducibility of diagnosing micrometastases and isolated tumor cellsCancer, 2005